Srivastava Kavita, Srivastava Lily, Jain Tanvi
Faculty of Biotechnology, Institute of Biosciences and Technology, Shri Ramswaroop Memorial University , Barabanki, UP, India.
Department of Law, Sri J.N.M.P.G College, Associated College of Lucknow University, Lucknow, UP, India.
Perspect Clin Res. 2025 Jan-Mar;16(1):3-8. doi: 10.4103/picr.picr_273_23. Epub 2024 Aug 30.
Stem cell research is a major focus for scientific and medical communities worldwide due to the potential for stem cells to restore function lost due to disease, trauma, congenital abnormalities, and aging. Stem cells can repair, replace, or regenerate damaged cells, tissues, or organs, making them an important area of research in regenerative medicine. India is emerging as a prominent hub for the development of stem cell therapy (SCT), and it is important to assess the current state of stem cell research in India and the potential for advancement to promote stem cell-based therapy. However, several barriers exist in India that are hindering the rapid expansion of SCT. This article examines the existing regulations that govern SCT in India, comparing them with regulations in developed nations, particularly for patients with unmet clinical needs. It also highlights the importance of public education in dispelling myths, addressing concerns, and promoting the benefits of stem cell research. The article concludes with recommendations for enhancing safety measures in SCT applications to ensure ethical practices and patient well-being.
由于干细胞具有恢复因疾病、创伤、先天性异常和衰老而丧失的功能的潜力，干细胞研究是全球科学界和医学界的主要关注焦点。干细胞可以修复、替代或再生受损的细胞、组织或器官，使其成为再生医学研究的一个重要领域。印度正在成为干细胞治疗（SCT）发展的一个重要中心，评估印度干细胞研究的现状以及推进基于干细胞治疗的潜力非常重要。然而，印度存在一些障碍，阻碍了SCT的快速发展。本文研究了印度管理SCT的现有法规，并将其与发达国家的法规进行比较，特别是针对临床需求未得到满足的患者。它还强调了公众教育在消除误解、解决担忧和推广干细胞研究益处方面的重要性。文章最后提出了加强SCT应用安全措施的建议，以确保道德规范和患者福祉。
